AKT1 and breast carcinoma: Previous reports suggest that Silibinin, a potent anti-oxidant, has demonstrated the ability to induce autophagy induced cell death in fibrosarcoma, prostate and breast cancer cells through production of reactive oxygen species (ROS) as well as inhibiting MEK/ERK and PI3K/Akt pathways36–39.